Short Interest in BioSyent Inc. (OTCMKTS:BIOYF) Drops By 23.5%

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant drop in short interest in February. As of February 28th, there was short interest totalling 1,300 shares, a drop of 23.5% from the February 13th total of 1,700 shares. Based on an average daily trading volume, of 1,200 shares, the short-interest ratio is presently 1.1 days.

BioSyent Stock Performance

BIOYF opened at $7.84 on Tuesday. BioSyent has a fifty-two week low of $5.93 and a fifty-two week high of $8.90. The company’s 50-day moving average is $7.70 and its 200 day moving average is $7.89.

BioSyent Increases Dividend

The business also recently announced a dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, March 3rd were issued a $0.0347 dividend. This represents a dividend yield of 1.77%. The ex-dividend date of this dividend was Friday, February 28th. This is a positive change from BioSyent’s previous dividend of $0.03.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.